Actos tablets, formulated with the active compound Pioglitazone, are specifically developed to assist in regulating elevated blood sugar levels for individuals diagnosed with type 2 diabetes. These tablets are conveniently available in three dosage strengths: 7.5 mg, 15 mg, and 30 mg, catering to various treatment needs. The product is widely recognized under the primary brand name Actos, and is also distributed under alternative names such as Glitaris, Pioz, Pioglit, and Piokind, ensuring widespread availability across diverse markets.